Arlington Cancer Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma2 trials
• Lung cancer1 trial
• Mantle cell lymphoma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Biodesix, Inc.1 trial
• Celgene1 trial
• Xynomic Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

  NCT03600441· Phase 2· Xynomic Pharmaceuticals, Inc.· Source

• Active, not recruiting

  Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

  NCT03289780· Biodesix, Inc.· Source

Closed trials

• Completed

  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

  NCT01996865· Phase 3· Celgene· Source